Key warnings include risk of thyroid C-cell tumors, pancreatitis, gallbladder disease, risk of acute kidney injury with severe gastrointestinal adverse reactions, and potential diabetic retinopathy complications
[DOI] [PMC free article] [PubMed] [Google Scholar] [14].Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MT, Wadden TA, Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine 384(11) (2021) 9891002
Youre looking at a biological masterclass: the blueprint of a high-tech, highly efficient internal pharmacy that lives right inside your gut
Bevilacqua A, et al
McGowan BM, Bruun JM, Capehorn M, et al